Proteolytic processing induces a conformational switch required for antibacterial toxin delivery

Authors:

Abstract
Many Gram-negative bacteria use CdiA effector proteins to inhibit the growth of neighboring competitors. CdiA transfers its toxic CdiA-CT region into the periplasm of target cells, where it is released through proteolytic cleavage. The N-terminal cytoplasm-entry domain of the CdiA-CT then mediates translocation across the inner membrane to deliver the C-terminal toxin domain into the cytosol. Here, we show that proteolysis not only liberates the CdiA-CT for delivery, but is also required to activate the entry domain for membrane translocation. Translocation function depends on precise cleavage after a conserved VENN peptide sequence, and the processed ∆VENN entry domain exhibits distinct biophysical and thermodynamic properties. By contrast, imprecisely processed CdiA-CT fragments do not undergo this transition and fail to translocate to the cytoplasm. These findings suggest that CdiA-CT processing induces a critical structural switch that converts the entry domain into a membrane-translocation competent conformation.
Funding Information
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM102318, GM115586, GM102318, GM117930, GM102318)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI121789)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
  • Division of Intramural Research (AI21789)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences

This publication has 70 references indexed in Scilit: